Effect of two carbohydrate-modified tube-feeding formulas on metabolic responses in patients with type 2 diabetes

Nutrition

Volumn 24, Issue 10, 2008, Pages 990-997

  Voss, Anne Coble ^a   Maki, Kevin C ^b   Garvey, W Timothy ^c   Hustead, Deborah S ^a   Alish, Carolyn ^a   Fix, Brenda ^a   Mustad, Vikkie A ^a  

^a ABBOTT LABORATORIES   (United States)

^b Provident Clinical Research   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

3 Fatty acids; Enteral formulas; Fructo oligosaccharides; Glucagon like peptide 1; Glucose; Insulin; Monounsaturated fatty acids; Slowly digested carbohydrate; Tube feeding; Type 2 diabetes

Indexed keywords

CARBOHYDRATE; GLUCAGON LIKE PEPTIDE 1;

ADULT; AGED; ARTICLE; ARTIFICIAL MILK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH DISTENSION; TREATMENT RESPONSE; TUBE FEEDING;

ADOLESCENT; ADULT; AGED; AREA UNDER CURVE; BLOOD GLUCOSE; CARBOHYDRATE METABOLISM; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DIETARY CARBOHYDRATES; DIETARY FATS, UNSATURATED; DIGESTION; DOUBLE-BLIND METHOD; FEMALE; FOOD, FORMULATED; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INSULIN; MALE; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 50549083559     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2008.06.009     Document Type: Article

References (51)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
3. Choudhary P. Review of dietary recommendations for diabetes mellitus. Diabetes Res Clin Pract 65 suppl 1 (2004) S9-S15
4. Diabetes and Nutrition Study Group of the European Association for the Study of Diabetes. Recommendations for the nutritional management of patients with diabetes mellitus. Eur J Clin Nutr 54 (2000) 353-355
5. American Diabetes Association. Nutrition recommendations and interventions for diabetes. A position statement of the American Diabetes Association. Diabetes Care 30 (2007) S48-S65
6. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Nutrition therapy. Can J Diabetes 27 (2003) S27-S31
7. Connor H., and Nutrition Subcommittee of the Diabetes Care Advisory Committee of Diabetes UK. The implementation of nutritional advice for people with diabetes. Diabet Med 20 (2003) 786-807
8. Cashmere K.A., Costill D.L., Cataland S., and Hecker A.L. Serum endocrine and glucose response elicited from ingestion of enteral feedings. Fed Proc 40 (1981) 440A
9. Stevens C., Costill D.L., and Maxwell B. Impact of carbohydrate source and osmolality on gastric emptying rates of liquid nutritionals. JPEN 3 (1979) 32
10. Elia M., Ceriell A., Laube H., Sinclair A.J., Engfer M., and Stratton R.J. Enteral nutritional support and use of diabetes-specific formulas for patients with diabetes. A systematic review and meta-analysis, Diabetes Care 28 (2005) 2267-2279
11. Pohl M., Mayr P., Mertl-Roetzer M., Lauster F., Lerch M., Eriksen J., et al. Glycaemic control in type II diabetic tube-fed patients with a new enteral formula low in carbohydrates and high in monounsaturated fatty acids: a randomised controlled trial. Eur J Clin Nutr 59 (2005) 1221-1232
12. Craig L.D., Nicholson S., Silverstone F., and Kennedy R.D. Use of a reduced-carbohydrate, modified-fat enteral formula for improving metabolic control and clinical outcomes in long-term care residents with type 2 diabetes: results of a pilot trial. Nutrition 14 (1998) 529-534
13. Avignon A., Radauceanu A., and Monnier A.L. Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care 20 (1997) 1822-1826
14. Monnier L., Lapinski H., and Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of patients with T2DM: variations with increasing levels of HbA(1c). Diabetes Care 3 (2003) 881-885
15. O'Dea K., Snow P., and Nestel P. Rate of starch hydrolysis in vitro as a predictor of metabolic responses to complex carbohydrate in vivo. Am J Clin Nutr 34 (1981) 1991-1993
16. Jenkins D.L., Kendall C.W., Augustin L.S., Francheschi S., Hamidi M., Marchie A., et al. Glycemic index: overview of implications in health and disease. Am J Clin Nutr 76 (2002) 266S-273
17. Wolever T.M., Yang M., Zeng X.Y., Atkinson F., and Brand-Miller J.C. Food glycemic index, as given in glycemic index tables, is a significant determinant of glycemic responses elicited by composite breakfast meals. Am J Clin Nutr 83 (2006) 1306-1312
18. Garg A. High-monounsaturated-fat diets for patients with diabetes mellitus: a meta-analysis. Am J Clin Nutr 67 suppl (1998) 577S-582
19. Ros E. Dietary cis-monounsaturated fatty acids and metabolic control in type 2 diabetes. Am J Clin Nutr 78 (2003) 617S-625
20. Rocca A.S., LaGreca J., Kalitsky J., and Brubaker P.L. Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1. Endocrinology 142 (2001) 1148-1155
21. Lichtenstein A.H., Appel L.J., Brands M., Carnethan M., Daniesl S., Franch H.A., et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 114 (2006) 82-96
22. West S.G., Hecker K.D., Mustad V.A., Nicholson S., Schoemer S.L., Wagner P., et al. Acute effects of monounsaturated fatty acids with and without omega-3 fatty acids on vascular reactivity in individuals with type 2 diabetes. Diabetologia 48 (2005) 13-22
23. Mustad V.A., DeMichele S., and Huang Y.S. Differential effects of n-3 polyunsaturated fatty acids on metabolic control and vascular reactivity in the type 2 diabetic ob/ob mouse. Metabolism 55 (2006) 1365-1374
24. Kunst A., Draeger B., and Ziegenhorn Z. D-Glucose: UV-methods with hexokinase and glucose-6 phosphate dehydrogenase. In: BergMeyer H.U. (Ed). Methods of enzymatic analysis (1983), Verlag Chemie, Weinheim, Germany 163-172
25. Nieman T. Encyclopedia of analytical science (1995), Academic Press, Orlando, FL
26. SAS Institute. SAS software, version 8.2 of the SAS system for Windows (1999-2001), SAS Institute, Cary, NC
27. Drucker D.J. The biology of incretin hormones. Cell Metab 3 (2006) 153-165
28. Nuttall F.Q., Gannon M.C., Burmeister L.A., Lane J.T., Pyzdrowski K.L., et al. The metabolic response to various doses of fructose in type II diabetic subjects. Metabolism 41 (1992) 510-517
29. Wolf B.W., Humphrey P.M., Hadley C.W., Maharry K.S., Galreb K.A., Firkins J.L., et al. Supplemental fructose attenuates postprandial glycemia in Zucker fatty fa/fa rats. J Nutr 132 (2002) 1219-1223
30. Wakabayashi S., Kishimoto Y., and Matsuoka A. Effects of indigestible dextrin on glucose tolerance in rats. J Endocrinol 144 (1995) 533-538
31. Wheeler M.L., Fineberg S.E., Gibson R., Fineberg N., et al. Metabolic response to oral challenge of hydrogenated starch hydrolysate versus glucose in diabetes. Diabetes Care 13 (1990) 733-740
32. Foster-Powell K., Holt S.H., and Brand-Miller J.C. International table of glycemic index and glycemic load values. Am J Clin Nutr 76 (2002) 5-56
33. Jenkins D.J., Wolever T.M., Taylor R.H., Barker H., Fielder H., Baldwin J.M., et al. Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr 34 (1981) 362-366
34. Wolever T.M.S., Bentum-Williams A., and Jenkins D.J.A. Physiologic modulation of plasma FFA concentrations by diet: metabolic implications in non-diabetic subjects. Diabetes Care 18 (1995) 962-970
35. Barclay A.W., Petocz P., McMillan-Price J., Flood V.M., Prvan T., Mitchell P., and Brand-Miller J.C. Glycemic index, glycemic load, and chronic disease risk-a meta-analysis of observational studies. Am J Clin Nutr 87 (2008) 627-637
36. Tiwari S., Riazi S., and Ecelbarger C.A. Insulin's impact on renal sodium transport and blood pressure in health, obesity and diabetes. Am J Physiol Renal Physiol 293 (2007) F974-F984
37. Kalaitzidis R., Tsimihodimos V., Bairaktari E., Kostantinos C., Siamopoulos M.E., et al. Disturbances of phosphate metabolism: another feature of metabolic syndrome. Am J Kidney Dis 45 (2005) 851-858
38. Kern W., Peters A., Born J., Fehm H.L., and Schultes B. Changes in blood pressure and plasma catecholamines during prolonged hyperinsulinemia. Metabolism 54 (2005) 391-396
39. Després J.-P., Lamarche B., Mauriège P., Cantin B., Dagnenais G.R., Moorjani S., Lupien P.-J., et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. New Engl J Med 334 (1996) 952-958
40. Butler A.E., Janson J., Bonner-Weir S., Ritzel R., Rizza R.A., Butler P.C., et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52 (2003) 102-110
41. Clement S., Braithwaite S.S., Magee M.F., Ahman A., Smith E.P., Schafer R.G., and Hirsh I.B. Management of diabetes and hyperglycemia in hospitals. Diabetes Care 27 (2004) 553-591
42. Falanga V. Wound healing and its impairment in the diabetic foot. Lancet 366 (2005) 1736-1743
43. Mannucci E., Ognibene A., Cremasco F., et al. Glucagon-like peptide (GLP)-1 and leptin concentrations in obese patients with type 2 diabetes mellitus. Diabet Med 17 (2000) 713-719
44. Qudduse S., Vahl T.P., Hanson K., Prigeon R.L., and A'Lessio D.A. Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans. Diabetes Care 26 (2003) 791-798
45. Cani P.D., Neyrinck A.M., Maton N., and Delzenne N.M. Oligofructose promotes satiety in rats fed a high-fat diet. Involvement of glucagon-like peptide-1. Obes Res 13 (2005) 1000-1007
46. Delzenne N.M., Cani P.D., Daubioul C., and Neyrinck A.M. Impact of inulin and oligofructose on gastrointestinal peptides. Br J Nutr 93 suppl 1 (2005) S157-S161
47. Sidebottom R., Curran J.S., Williams P.R., Kanarek K.S., and Bramson R.T. Effects of long-chain vs medium-chain triglycerides on gastric emptying time in premature infants. J Pediatr 102 (1983) 48-50
48. Beysen C., Karpe F., Fielding B.A., Clark A., Levy J., Frayn K., et al. Interaction between specific fatty acids, GLP-1 and insulin secretion in humans. Diabetologia 45 (2002) 1533-1541
49. Joannic J.L., Auboiron S., Raison J., Basdevant A., Bornet F., and Guy-Grand B. How the degree of unsaturation of dietary fatty acids influences the glucose and insulin responses of different carbohydrates in mixed meals. Am J Clin Nutr 65 (1997) 1427-1433
50. Kirk J.K. The risk of hyperglycemic, hyperosmolar, nonketotic coma (HHNK) in elderly patients with diabetes. Diabetes Spectrum 6 (1993) 324-325
51. Reed R.L., and Mooradian A.D. Treatment of diabetes in the elderly. Am Fam Physician 44 (1991) 917-924